


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 11 Jan 2022
Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development
Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development
HSMN NewsFeed - 3 Jan 2022
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
HSMN NewsFeed - 30 Dec 2021
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
HSMN NewsFeed - 29 Dec 2021
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
HSMN NewsFeed - 27 Dec 2021
VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D
VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D
HSMN NewsFeed - 23 Dec 2021
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
HSMN NewsFeed - 14 Dec 2021
HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, Chief Medical Officer
HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, Chief Medical Officer
HSMN NewsFeed - 8 Dec 2021
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
HSMN NewsFeed - 7 Dec 2021
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 3 Dec 2021
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
HSMN NewsFeed - 24 Nov 2021
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
